Seeking Alpha

More on Quidel (QDEL): Q4 easily beats both EPS and revenue estimates as total sales rise over...

More on Quidel (QDEL): Q4 easily beats both EPS and revenue estimates as total sales rise over 40% Y/Y, driven largely by growth of infectious disease products due to the onset of an early and severe flu and respiratory disease season.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|